Charan Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.72 M
- Company Age 19 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.93 Cr
- Satisfied Charges ₹ 30.80 Cr
- Revenue Growth 0.37%
- Profit Growth -4950.82%
- Ebitda -15.53%
- Net Worth -8.12%
- Total Assets -19.84%
About Charan Biotech
Charan Biotech Private Limited (CBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 August 2005 and has a history of 19 years and five months. Its registered office is in Ameerpet Hyd 016, Telangana.
The Corporate was formerly known as Sai Balaji Induction Furnaces Private Limited. The Company is engaged in the Metals And Minerals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.72 M.
The company currently has active open charges totaling ₹12.93 Cr. The company has closed loans amounting to ₹30.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Aduru Ramanjineylu and Thotakura Balaji serve as directors at the Company.
Company Details
-
LocationAmeerpet Hyd 016, Telangana
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74110TG2005PTC047126
-
Company No.
047126
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Aug 2005
-
Date of AGM
27 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Charan Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aduru Ramanjineylu
|
Director | 15-Jul-2020 | Current |
|
Thotakura Balaji
|
Director | 10-Aug-2020 | Current |
Financial Performance of Charan Biotech.
Charan Biotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.37% increase. The company also saw a substantial fall in profitability, with a 4950.82% decrease in profit. The company's net worth dipped by a decrease of 8.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Charan Biotech?
Unlock access to Charan Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹129.30 M
₹308.00 M
Charges Breakdown by Lending Institutions
- Canara Bank : 12.93 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Dec 2020 | Canara Bank | ₹12.93 Cr | Open |
| 24 Aug 2009 | State Bank Of India | ₹30.80 Cr | Satisfied |
How Many Employees Work at Charan Biotech?
Unlock and access historical data on people associated with Charan Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Charan Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Charan Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
